Research Article
Safety and Efficacy of the C-117 Formula for Vulnerable Carotid Artery Plaques (Spchim): A Randomized Double-Blind Controlled Pilot Study
Table 2
Baseline characteristics.
| | C-117 formula group | Placebo group | | (n=59) | (n=59) |
| Basic Features |
| Age (Yr) | 64.76 ± 7.079 | 63.5 ± 7.691 | ≥60, n (%) | 46(78.0%) | 43(72.9%) | Gender | | | Female | 34(57.6%) | 28(47.5%) | Male | 25(42.4%) | 31(52.5%) | Height (cm) | 161.39 ± 7.8 | 162.46 ± 6.18 | Weight (kg) | 62.92 ± 11.0 | 62.13 ± 8.58 | Systolic blood pressure, , (mmHg) | 126.29 ± 11.33 | 127.56 ± 13.85 | Diastolic blood pressure, , (mmHg) | 71.88 ± 8.81 | 74.32 ± 11.37 |
| Past history, n (%) |
| Ischemic stroke or TIA | 8(13.6%) | 9(15.3%) | Diabetes | 14(23.7%) | 13(22.0%) | Hypertension | 30(50.8%) | 37(62.7%) | Hyperuricemia | 6(10.2%) | 5(8.5%) | Other medical history | 30(50.8%) | 31(52.5%) |
| Personal life history, n (%) |
| Exercise | Often | 33(55.9%) | 36(61.0%) | Occasionally | 26(44.1%) | 22(37.3%) | Never | 0(0%) | 1(1.75%) | Eat vegetables every day | 55(93.2%) | 52(88.1%) | Eat fruit every day | 35(59.3%) | 34(57.6%) | Smoking history | 7(11.9%) | 9(15.3%) | Drinking history | 19(32.2%) | 11(18.6%) |
| Taking lipid-lowering drugs, n (%) | | |
| Atorvastatin calcium tablets | 48(81.4%) | 46(78.0%) | Other lipid-lowering drugs | 10(16.9%) | 10(16.9%) | Not taken | 1(1.7%) | 3(5.1%) |
| Combination therapy, n (%) | | |
| Antihypertensive drugs | 28(47.5%) | 30(50.8%) | Hypoglycaemic agents | 10(16.9%) | 11(18.6%) | Antiplatelet drug | 12(20.3%) | 9(15.3%) | Other medication | 20(33.9%) | 12(20.3%) |
|
|